FIELD: medicine. SUBSTANCE: method involves taking off of donor blood and addition of preserving agent (citrate) and HERES and contrical following by plasma separation, centrifugation, purification on barium sulfate through asbestos plates and lyophilization for 23-24 h at temperature 5 C, not above. Positive effect: product can be used for 1 year. EFFECT: enhanced stability of the end product. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCTION OF CONTROL PLASMA WITH NORMAL LEVEL OF PROTHROMBIN COMPLEX | 2004 |
|
RU2270020C2 |
| METHOD OF NORMAL PLASMA POOL PREPARING | 2000 |
|
RU2174841C1 |
| METHOD OF REAGENT PREPARING FOR DETERMINATION OF ACTIVATED PARTIAL THROMBOPLASTIN TIME | 1990 |
|
RU1767743C |
| METHOD FOR OBTAINING HIGH ACTIVITY RAW MATERIALS FOR PRODUCING COMPLETE SOLUBLE THROMBOPLASTIN | 1999 |
|
RU2160111C1 |
| METHOD OF PURIFICATION OF HUMAN IMMUNOGLOBULIN ANTITETANUS PREPARATION | 1988 |
|
SU1628293A1 |
| METHOD OF PREPARING IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION | 1992 |
|
RU2068695C1 |
| METHOD OF CONSERVATION OF RAW ACTIVITY FOR PREPARING FULL SOLUBLE THROMBOLASTIN BEFORE AND DURING LYOPHILIZATION | 2000 |
|
RU2161975C1 |
| METHOD OF PREPARING ORGANOSPECIFIC HOMEOPATHIC PREPARATIONS STIMULATING MYELOID AND LYMPHOID HEMOPOIESIS STEMS | 1995 |
|
RU2083213C1 |
| METHOD OF PREPARING HUMAN ANTISTAPHYLOCOCCUS IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION | 1996 |
|
RU2141341C1 |
| METHOD OF PREPARING PRESERVING SOLUTIONS FOR BONE MARROW STORING | 1996 |
|
RU2120211C1 |
